Gynecology

Nishita Pondugula, MD, MS, explains her session surrounding associations of gestational weight gain and hypertensive pregnancy disorders with prepregnancy GLP-1 exposure.

Backed by phase 3 data showing an overall success rate of 58.5% versus 60.2% for IV imipenem-cilastatin, tebipenem HBr has been approved by the FDA as the first oral carbapenem antibiotic for the treatment of complicated urinary tract infections in the US.

Susan Loeb-Zeitlin, MD, FACOG, breaks down the recently-updated ACOG guidance related to postmenopausal bleeding.

Melissa Loseke, DO, highlighted evidence that testosterone therapy in women may improve energy, mood, cognition, and cardiometabolic markers beyond sexual function.

The FDA has approved Wockhardt’s cefepime and zidebactam, a novel intravenous antibiotic that targets multiple penicillin-binding proteins to treat adults with complicated urinary tract infections.

These are the top 5 headlines you might have missed from May 2026.

Esther H. Chung, MD, discusses how earlier fertility education, emotional screening, and structured referrals can improve patient experiences and outcomes in infertility care.

David Shalowitz explains why experts now recommend a dual approach for most patients with postmenopausal bleeding due to limitations in ultrasound accuracy.

Earlier initiation of conservative therapies may improve outcomes and reduce the need for advanced treatment in stress urinary incontinence.

Cervical cancer screening increased by 2.2 percentage points after program implementation, though 12.6% of eligible individuals received testing kits.

Sameena Rahman, MD, FACOG, asserts that the word "metabolic" in PMOS should fundamentally change clinical perceptions, transforming it from a GYN issue into a universally treated systemic condition.

Sameena Rahman, MD, FACOG, highlights that renaming PCOS to PMOS is vital for recognizing the condition as a systemic metabolic disorder rather than a simple ovarian issue.

The vaginal insert will be available starting May 19, 2026.

According to a publication in The Lancet, a multistep process was used to generate a new name to avoid misleading references to ovarian cysts while accurately reflecting the condition's diverse features.

Elizabeth Alderman, MD, and Julie Samuels explain new research detailing what data exists for period poverty in high-income countries, as well as the lack of data on established interventions.

Take a look back at our coverage (so far) of the 2026 ACOG meeting in Washington, DC

The review of over 120 studies published since 2024 found no credible evidence linking HPV vaccination to serious adverse pregnancy outcomes or other long-term health risks.

Contemporary OB/GYN will be on site in Washington, D.C. to cover the latest data out of the 75th Annual ACOG Clinical & Scientific Meeting.

Utepreva LLC has launched a proprietary, FDA-cleared endometrial sampler that combines suction, disruption, and absorption to improve tissue yield in 20-second office procedures.

Ramu Perni highlights how the "one tube" workflow streamlines obstetric practices by enabling add-on RBC and platelet antigen tests.

The incidence of SUI at 6 weeks post partum was 8.7% for the PEFLOW group compared to 13.9% for those receiving usual care (P = .03).

ACOG now recommends a combination of transvaginal ultrasonography and endometrial tissue sampling for the initial evaluation of most patients presenting with postmenopausal bleeding.

According to ACOG, approximately 90% of patients diagnosed with endometrial cancer have postmenopausal bleeding. Read more on the College's updated recommendations below.

Moving LiSWT into formal postpartum care guidelines will require randomized controlled trials with adequate sample sizes, defined treatment parameters, long-term follow-up, and dedicated safety data in lactating patients, with cost-effectiveness analysis also identified as a priority research direction.

Scott Sullivan, MD, highlights that a third of Virginia is a maternity desert, creating even more severe gaps for patients requiring maternal-fetal medicine.